Oppenheimer Rates BrightView (BV) buy, $17 Price Target

Oppenheimer maintains a positive outlook on BrightView, setting a $17 price target, a 28.89% upside from the current price.

Reviewed by automated data checks against the source data. How we make and check alerts

Oppenheimer rated BrightView Holdings, Inc. ($BV) "buy" with a $17 price target on June 17, 2026.

Since the rating, $BV is up 11.1% after 1 week, up 15.0% after 1 month and down 16.6% to date (from the $12.63 close on Jun 17, 2026).

BV BrightView Holdings, Inc.
$10.54 -16.35% year to date
Daily close · Oct 16, 2026

Key Points

  • Oppenheimer reiterated its buy rating on BrightView Holdings, Inc. with a price target of $17.
  • Oppenheimer's $17 price target implies 28.89% upside from BrightView Holdings, Inc.'s ($BV) current $13.19 share price.
  • BrightView's stock, trading on the NYSE under the ticker BV, is priced at $12.78 with a market cap of about $1.19 billion.
  • Recent insider purchases and diverse analyst opinions reflect varied perspectives on BrightView's future performance.

Get $BV trade alerts by text

We text you when insiders, Congress or big funds trade $BV. Free.

Not investment advice. TradeTexts is not a registered investment adviser, and this automated BrightView Holdings, Inc. alert may contain errors. Disclosures

On June 17, 2026, Oppenheimer reiterated its buy rating on BrightView Holdings, Inc. (NYSE: BV) with a price target of $17. The stock is currently trading at $12.78.

Other Institutional Activity in BrightView Holdings, Inc.

Several institutional investors have adjusted their positions in BrightView. Dimensional Fund Advisors LP increased its holdings by 192,376 shares, ending with about 5.27 million shares valued at $62.1 million. Cooke & Bieler LP also boosted its stake by 214,102 shares, now holding approximately 3.86 million shares worth $45.5 million. Meanwhile, BlackRock, Inc. slightly trimmed its position by 73,425 shares, maintaining around 5.22 million shares valued at $61.5 million.

BrightView Holdings, Inc. Stock Up 23.8%

Shares of BrightView Holdings, Inc. (NYSE: BV) are trading near $12.78. The company has a market capitalization of approximately $1.19 billion and a forward P/E ratio of 17.17. Its beta of 1.205 suggests moderate volatility compared to the market. The stock's 52-week range is between $11.06 and $17.11, with a 50-day moving average of $12.38 and a 200-day moving average of $12.79. BrightView maintains a current ratio of 1.229 and a quick ratio of 1.061, with a debt-to-equity ratio of 51.633.

12-month forecast

$BV price target

BrightView Holdings, Inc. daily closes and this analyst's $17 target. Not advice.

Recent Earnings

BrightView reported revenue of about $2.73 billion, reflecting a growth rate of 6.1%. The company's net margin stands at 1.7%, and return on equity is 2.6%. Earnings per share are $0.03. The next earnings report is scheduled for August 5, 2026.

Insider Buying and Selling at BrightView Holdings, Inc.

Several insiders have recently purchased shares of BrightView. On April 2, 2026, EVP and Chief Commercial Officer Michael Joe Dozier acquired 42,700 shares. Earlier, on March 4, 2026, Francisco Lopez Jr., James Abrahamson, Jane Okun Bomba, Mara Swan, and William Cornog each bought 11,833 shares.

Analysts Set New Price Targets

On June 17, 2026, Oppenheimer reiterated its buy rating on BrightView Holdings, Inc. with a $17 price target. Previously, on May 7, 2026, JP Morgan upgraded the stock to a hold rating with a $14 target. The consensus recommendation is a buy, with an average target price of $16.64 based on nine analyst opinions.

About BrightView Holdings, Inc.

BrightView Holdings, Inc., headquartered in Blue Bell, Pennsylvania, is a leading provider of commercial landscaping services in the United States. With around 18,200 employees, the company operates in two main segments: Maintenance Services and Development Services. BrightView offers a range of services, including landscaping, irrigation, and snow removal, catering to various clients such as corporate entities, municipalities, and healthcare facilities. The company also serves as the official field consultant to Major League Baseball.

Bottom Line

Oppenheimer's reiteration of its buy rating and a $17 price target suggests confidence in BrightView Holdings, Inc.'s potential. Investors keep a close watch on such analyst updates to gauge future performance. Remember, these ratings reflect past analyses and may not fully capture current market dynamics.

Source: Oppenheimer's rating change on $BV (Jun 17, 2026). Written by software, not financial advice. How we make alerts

Get $BV trade alerts by text